Journal profile · RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Revista Espanola de Medicina Nuclear e Imagen Molecular

ISSN 2253-654X · eISSN 2253-8070 · Elsevier Espana · SPAIN

Revista Espanola de Medicina Nuclear e Imagen Molecular: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.09; hybrid open access; APC about USD 3,400; review about 69 days (submission to acceptance, publisher); community-reported acceptance: easy; 94 articles in 2025; indexed in SCIE and Scopus.

Impact factor1.09Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time69 daysPublisher-reported, submission to acceptance · community reports 6–12 weeks
APCUSD 3,400Hybrid journal: charged only for open-access articles
AcceptanceEasyCommunity average
Articles per year942025 · OpenAlex count

Scope

Aims, scope and focus

Revista Espanola de Medicina Nuclear e Imagen Molecular is published by Elsevier Espana and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Medical Imaging Techniques and Applications, Medical Imaging and Pathology Studies and Prostate Cancer Treatment and Research, together about 24.3% of its articles. Its main subfields are Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)

The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging.The Journal, which publishes 6 regular issues per year, has the promotion of research and continuing education in all fields of Nuclear Medicine as its main aim. For this, its principal sections are Originals, Images of Interest and Special Collaboration articles.The works may be submitted in Spanish or English and are subjected to a peer review process. La Revista Española de Medicina Nuclear e Imagen Molecular, fundada en 1982, es el órgano oficial de expresión de la Sociedad Española de Medicina Nuclear e Imagen Molecular.La revista, que publica seis números regulares al año, tiene como principal objetivo promocionar la investigación y la formación continuada en todos los ámbitos de la Medicina Nuclear. Para ello, sus secciones principales son Originales, Imágenes de Interés y artículos de Colaboración especial. Los trabajos pueden enviarse en español o en inglés y son sometidos a un proceso de revisión por pares.La Revista Española de Medicina Nuclear e Imagen Molecular is an online only, hybrid publication, peer-reviewed journal in Nuclear and Medicine and Molecular Imaging. REMNIMoffers the quality, rigor, and visibility you expect from its companion title,.EJR Open will rapidly communicate the most up-to-date international diagnostic imaging research to Radiologists at all levels of training. It aims to publish high quality, evidence-based, original research articles as well as authoritative reviews in areas of special interest. The Journal will focus on state-of-the-art research in diagnostic imaging of human and animal subjects with the exclusive objective of translating this into clinical practice to improve patient outcomes.

From the journal's Aims & Scope

Research area (LetPub): RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Editor-in-chief Elena GoñiPublisher website

Editorial board by country: none in mainland China; most named Spain 86, United States 3 (89 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Medical Imaging Techniques and ApplicationsMedicine12.4%
  2. Medical Imaging and Pathology StudiesMedicine6.4%
  3. Prostate Cancer Treatment and ResearchMedicine5.4%
  4. Neuroendocrine Tumor Research AdvancesMedicine5%
  5. Cancer Diagnosis and TreatmentMedicine4.6%
  6. Radiomics and Machine Learning in Medical ImagingMedicine4.6%
  7. Sarcoma Diagnosis and TreatmentMedicine4.5%
  8. Radiopharmaceutical Chemistry and ApplicationsMedicine4.4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorRadiology, Nuclear Medicine & Medical ImagingZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorRadiology, Nuclear Medicine & Medical ImagingZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorRadiology, Nuclear Medicine & Medical ImagingZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

PubMedPublisher website

Other: Crossref

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
1.09LetPub ·
Impact factor (publisher)
1.2Publisher website ·
CiteScore 2026-06
1LetPub ·
CiteScore (publisher)
1Publisher website ·
SJR 2026-06
0.22LetPub ·
SNIP 2026-06
0.29LetPub ·
h-index
18LetPub ·
h-index
21OpenAlex ·
i10-index
96OpenAlex ·
2-year mean citedness
0.02OpenAlex ·
Self-citation rate
8.3%LetPub ·
Share of gold OA articles
6.35%LetPub ·

Volume

Articles per year
45LetPub ·

Articles by year OpenAlex count · 1,981 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026350101
20259435
20247966
2023350149
202279215
20211191056

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Publisher-reported review time from the journal's website

69 dayssubmission to acceptance · community reports 6–12 weeks

The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.

Figures by source

Average review time (community reports)
6–12 weeksLetPub ·
Average acceptance (community reports)
EasyLetPub ·
Submission to first decision
5 daysPublisher website ·
First decision after review
32 daysPublisher website ·
Submission to acceptance
69 daysPublisher website ·
Peer review
Double anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 3,400 / EUR 3,180 / GBP 2,720 / JPY 421,700——
Publisher websiteUSD 3,400——

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Article types accepted8, with length limits
  1. clinical notesits principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articlesLength not stated
  2. editorialAny article submitted to this journal must follow the guidelines described in this author guide, so it is essential to consult it before submitting manuscripts.…Length not stated
  3. images of interestits principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articlesLength not stated
  4. letters to the editorAny article submitted to this journal must follow the guidelines described in this author guide, so it is essential to consult it before submitting manuscripts.…Length not stated
  5. literature reviewAny article submitted to this journal must follow the guidelines described in this author guide, so it is essential to consult it before submitting manuscripts.…Length not stated
  6. original articleAny article submitted to this journal must follow the guidelines described in this author guide, so it is essential to consult it before submitting manuscripts.…main text ≤ 6,500 words
  7. originalsits principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articlesLength not stated
  8. special collaborationits principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articlesLength not stated
Publisher website
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
Authorship Authorship

All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.

Source ↗Publisher website ·
Conflicts of interest Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…

Source ↗Publisher website ·
License & copyright Copyright

Journal Publishing Agreement Model summary

Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…

Source ↗Publisher website ·
Open access Open access

Please visit our Open Access page from the Journal Homepage for more information.

Source ↗Publisher website ·
Peer review Peer review

Double anonymized review Model summary

This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…

Source ↗Publisher website ·
Preprints Preprints

Preprint sharing allowed Model summary

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Elsevier Espana
Country or region
SPAIN
Language
Multi-Language
ISSN
2253-654X
Electronic ISSN
2253-8070
Society / sponsor
Spanish Society of Nuclear Medicine and Molecular Imaging
Official links

FAQ

Frequently asked questions about Revista Espanola de Medicina Nuclear e Imagen Molecular

What CAS zone is Revista Espanola de Medicina Nuclear e Imagen Molecular in?

In the 2025 upgraded edition of the CAS Journal Ranking, Revista Espanola de Medicina Nuclear e Imagen Molecular is in Zone 4 of Medicine, and in Zone 4 of the minor category Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Revista Espanola de Medicina Nuclear e Imagen Molecular?

The latest impact factor listed by LetPub is 1.09; CiteScore 1, h-index 21.

How long does peer review take at Revista Espanola de Medicina Nuclear e Imagen Molecular?

The publisher reports about 69 days (submission to acceptance); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Revista Espanola de Medicina Nuclear e Imagen Molecular based?

Of the 89 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Spain (86) and United States (3). Counted from the institutions listed on the board page; for reference only.

Which databases index Revista Espanola de Medicina Nuclear e Imagen Molecular?

According to LetPub and DOAJ records, Revista Espanola de Medicina Nuclear e Imagen Molecular is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.

Is Revista Espanola de Medicina Nuclear e Imagen Molecular open access, and what is the APC?

Revista Espanola de Medicina Nuclear e Imagen Molecular is a hybrid journal. For open-access publication: APC about USD 3,400.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .